[Asia Economy Reporter Hyungsoo Park] EagleVet, a specialized animal pharmaceutical company, is showing strong performance. The news that it became the first domestic animal pharmaceutical company to officially register an aldehyde-based disinfectant in the Chinese market appears to have influenced its stock price.
As of 9:33 AM on the 12th, EagleVet is trading at 7,160 KRW, up 16.05% from the previous day.
The disinfectant registered by EagleVet, "Glutaside," is a product primarily composed of glutaraldehyde and dimethyl cocobenzyl ammonium chloride. It has proven its efficacy and effectiveness through comparative tests with the original product, MSD's Omnicide. It can be used for hygiene management such as extermination of bacteria and viruses, and disinfection of livestock farms and livestock equipment, so its application range is expected to be broad.
In 2017, EagleVet became the first domestic animal pharmaceutical company to obtain EU-GMP certification. It exports to Southeast Asia, the Middle East, and Africa. The official product registration in China is the result of continuous efforts based on thorough quality control and disinfectant demand forecasting. Starting with China, it is evaluated to provide a breakthrough opportunity for future overseas business growth.
An EagleVet official stated, "The Chinese animal pharmaceutical market is a huge market worth about 8 trillion KRW, accounting for 23% of the global animal pharmaceutical market," and added, "With the disinfectant registration, we have secured export performance worth 1 million USD annually in the Chinese market."
He continued, "If the feed additive and injectable products currently undergoing additional registration are also officially registered, we expect to achieve a total performance of 10 million USD in the Chinese market by 2025."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
